Common Equity: The sum of all common equity items.
Blonder Tongue Laboratories, Inc. (BDRL) had Common Equity of $-2.04M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$2.92M |
|
$-0.31M |
|
$1.91M |
|
$1.01M |
|
$3.03M |
|
$-0.11M |
|
$-0.20M |
|
$-0.31M |
|
$-0.31M |
|
$-0.31M |
|
$-0.31M |
|
$-0.31M |
|
$-0.31M |
|
$-0.11M |
|
$0.12M |
|
14.47M |
|
14.47M |
|
$-0.02 |
|
$-0.02 |
|
| Balance Sheet Financials | |
$3.76M |
|
$0.16M |
|
$5.51M |
|
$9.27M |
|
$6.59M |
|
$2.13M |
|
$4.72M |
|
$11.31M |
|
|
Common Equity |
$-2.04M |
$-3.28M |
|
$-2.04M |
|
14.47M |
|
| Cash Flow Statement Financials | |
$0.18M |
|
$-0.08M |
|
$-0.04M |
|
$0.03M |
|
$0.09M |
|
$0.06M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.57 |
|
-- |
|
-- |
|
23.96 |
|
-2.37 |
|
34.50% |
|
-3.73% |
|
-3.73% |
|
-- |
|
-10.76% |
|
-10.76% |
|
$0.10M |
|
-- |
|
-- |
|
-- |
|
0.31 |
|
0.98 |
|
1.76 |
|
51.12 |
|
15.37% |
|
9.58% |
|
-3.39% |
|
-352.81% |
|
$-0.14 |
|
$0.01 |
|
$0.01 |
|